Pharmacists in Bossier City, Louisiana


93 Pharmacists found in Bossier City
male pharmacist

Dr. Shawn Michael Manor, PHARM.D.


Pharmacist
4918 Barksdale Blvd, Bossier City, LA 71112
318-549-2107    

female pharmacist

Stacey Dekinder


Pharmacist
4870 Airline Dr., Bossier City, LA 71111
318-746-2924    

female pharmacist

Stacy Wyatt, RPH


Pharmacist
3400 Airline Dr, Bossier City, LA 71111
318-741-6589     318-741-6675



female pharmacist

Dr. Stacy Manor, PHARMD


Pharmacist
2536 Airline Dr, Bossier City, LA 71111
318-747-8816    

female pharmacist

Dr. Tara Aileen Davis, PHARMD


Pharmacist
4890 Barksdale Blvd, Bossier City, LA 71112
318-747-4330     318-746-2773

female pharmacist

Tierney White


Pharmacist
4918 Barksdale Blvd, Bossier City, LA 71112
318-549-2107    

female pharmacist

Tiffany Cathleen Luse Upshaw, PHARM.D.


Pharmacist
3045 E Texas St, Bossier City, LA 71111
318-741-1776    

male pharmacist

Tijani Kolade, RPH


Pharmacist
2107 Airline Dr, Bossier City, LA 71111
318-742-5590    

male pharmacist

Mr. Timothy Joseph Doherty, RPH


Pharmacist
801 Benton Rd, Bossier City, LA 71111
318-742-3509    

male pharmacist

Tyler J Vincent, PHARMD


Pharmacist
2107 Airline Dr, Bossier City, LA 71111
318-742-5590    

male pharmacist

Mr. Wayne Dial


Pharmacist
2536 Airline Dr, Bossier City, LA 71111
318-422-0182    

male pharmacist

Dr. William Wayne Mccullar, R.PH., PHARMD


Pharmacist
3001 E Texas St, Bossier City, LA 71111
318-742-6600     318-742-4207

female pharmacist

Yasmeen Davis


Pharmacist
1050 George Dement Blvd, Bossier City, LA 71111
318-747-3162    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.